NYSE
MDT

Medtronic PLC

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Medtronic PLC Stock Price

Vitals

Today's Low:
$80.785
Today's High:
$81.77
Open Price:
$81.58
52W Low:
$73.8813
52W High:
$91.3011
Prev. Close:
$81.4
Volume:
3325774

Company Statistics

Market Cap.:
$108.31 billion
Book Value:
38.465
Revenue TTM:
$31.56 billion
Operating Margin TTM:
18.65%
Gross Profit TTM:
$21.72 billion
Profit Margin:
11.47%
Return on Assets TTM:
4.07%
Return on Equity TTM:
7.01%

Company Profile

Medtronic PLC had its IPO on 1978-01-13 under the ticker symbol MDT.

The company operates in the Healthcare sector and Medical Devices industry. Medtronic PLC has a staff strength of 95,000 employees.

Stock update

Shares of Medtronic PLC opened at $81.58 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $80.79 - $81.77, and closed at $80.98.

This is a -0.52% slip from the previous day's closing price.

A total volume of 3,325,774 shares were traded at the close of the day’s session.

In the last one week, shares of Medtronic PLC have slipped by -1.4%.

Medtronic PLC's Key Ratios

Medtronic PLC has a market cap of $108.31 billion, indicating a price to book ratio of 2.0201 and a price to sales ratio of 3.3559.

In the last 12-months Medtronic PLC’s revenue was $31.56 billion with a gross profit of $21.72 billion and an EBITDA of $8.33 billion. The EBITDA ratio measures Medtronic PLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Medtronic PLC’s operating margin was 18.65% while its return on assets stood at 4.07% with a return of equity of 7.01%.

In Q2.3333333333333, Medtronic PLC’s quarterly earnings growth was a negative -15.6% while revenue growth was a positive 4.5%.

Medtronic PLC’s PE and PEG Ratio

Forward PE
14.881
Trailing PE
30.0369
PEG
3.0399

Its diluted EPS in the last 12-months stands at $2.71 per share while it has a forward price to earnings multiple of 14.881 and a PEG multiple of 3.0399. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medtronic PLC’s profitability.

Medtronic PLC stock is trading at a EV to sales ratio of 3.8951 and a EV to EBITDA ratio of 13.4974. Its price to sales ratio in the trailing 12-months stood at 3.3559.

Medtronic PLC stock pays annual dividends of $2.73 per share, indicating a yield of 3.39% and a payout ratio of 51.02%.

Balance sheet and cash flow metrics

Total Assets
$90.78 billion
Total Liabilities
$9.05 billion
Operating Cash Flow
$-539000000.00
Capital Expenditure
$354 million
Dividend Payout Ratio
51.02%

Medtronic PLC ended 2024 with $90.78 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $90.78 billion while shareholder equity stood at $51.18 billion.

Medtronic PLC ended 2024 with $0 in deferred long-term liabilities, $9.05 billion in other current liabilities, 133050.00 in common stock, $30.27 billion in retained earnings and $41.44 billion in goodwill. Its cash balance stood at $1.34 billion and cash and short-term investments were $7.88 billion. The company’s total short-term debt was $519,000,000 while long-term debt stood at $24.46 billion.

Medtronic PLC’s total current assets stands at $21.87 billion while long-term investments were $0 and short-term investments were $6.54 billion. Its net receivables were $5.81 billion compared to accounts payable of $2.24 billion and inventory worth $5.67 billion.

In 2024, Medtronic PLC's operating cash flow was $-539000000.00 while its capital expenditure stood at $354 million.

Comparatively, Medtronic PLC paid $0.51 in dividends in 2024.

Other key metrics

Current Trading Price
$80.98
52-Week High
$91.3011
52-Week Low
$73.8813
Analyst Target Price
$92.68

Medtronic PLC stock is currently trading at $80.98 per share. It touched a 52-week high of $91.3011 and a 52-week low of $91.3011. Analysts tracking the stock have a 12-month average target price of $92.68.

Its 50-day moving average was $84.54 and 200-day moving average was $82.42 The short ratio stood at 1.56 indicating a short percent outstanding of 0%.

Around 9.7% of the company’s stock are held by insiders while 8452.6% are held by institutions.

Frequently Asked Questions About Medtronic PLC

The stock symbol (also called stock or share ticker) of Medtronic PLC is MDT

The IPO of Medtronic PLC took place on 1978-01-13

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$5.35
-0.15
-2.73%
$17.19
-1.41
-7.58%
RISHI TECHTEX LTD. (RISHITECH)
$26.39
-0.02
-0.08%
$12.63
0.24
+1.94%
$3.78
0.25
+7.08%
$140.8
-14.65
-9.42%
Helbiz Inc (HLBZW)
$0.05
-0.01
-18.42%
$82.21
1.61
+2%
$12.99
-0.21
-1.59%
$223
-9.75
-4.19%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company’s Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company’s Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Address

20 On Hatch, Dublin, Ireland, 2